Cargando…
Changes in Cross-Sectional Area of Spinal Canal and Vertebral Body Under 2 Years of Teriparatide Treatment: Results from the EUROFORS Study
The treatment of osteoporotic patients with teriparatide is associated with a significant increase in bone formation and gain of bone mass. The purpose of this post hoc analysis was to determine if the cross-sectional area (CSA) of the spinal canal and the vertebral body is affected by teriparatide...
Autores principales: | Schnell, R., Graeff, C., Krebs, A., Oertel, H., Glüer, C.-C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903699/ https://www.ncbi.nlm.nih.gov/pubmed/20571786 http://dx.doi.org/10.1007/s00223-010-9386-8 |
Ejemplares similares
-
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
por: Farahmand, P., et al.
Publicado: (2013) -
Changes in Spinal Canal Diameter and Vertebral Body Height with Age
por: Kim, Kyung Hyun, et al.
Publicado: (2013) -
Teriparatide and vertebral fracture healing in Ankylosing Spondylitis
por: Biro, Izolda, et al.
Publicado: (2017) -
Comparative Effects of Teriparatide and Risedronate in Glucocorticoid-Induced Osteoporosis in Men: 18-Month Results of the EuroGIOPs Trial
por: Glüer, Claus-C, et al.
Publicado: (2013) -
Reference values for the cervical spinal canal and the vertebral bodies by MRI in a general population
por: Nell, Christopher, et al.
Publicado: (2019)